BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

BRG.AU

30.25

-4.6%↓

LLC.AU

5.88

-3.13%↓

Search

Fisher & Paykel Healthcare Corp Ltd

Închisă

SectorImobiliare

32.26 1.96

Rezumat

Modificarea prețului

24h

Curent

Minim

30.4

Maxim

32.29

Indicatori cheie

By Trading Economics

Venit

153M

Vânzări

951M

P/E

Medie Sector

148.143

80.437

EPS

0.26

Randament dividend

1.26

Marjă de profit

16.106

Angajați

6,978

EBITDA

276M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+20.89% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.26%

5.59%

Următoarele câștiguri

28 mai 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-3.8B

18B

Deschiderea anterioară

30.3

Închiderea anterioară

32.26

Sentimentul știrilor

By Acuity

61%

39%

166 / 192 Clasament în Real estate

Fisher & Paykel Healthcare Corp Ltd Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

3 feb. 2025, 21:55 UTC

Market Talk

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2 feb. 2025, 22:06 UTC

Market Talk

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

28 nov. 2024, 21:55 UTC

Market Talk

F&P Healthcare Bear Sees Limited Scope for Guidance Upgrades -- Market Talk

18 nov. 2024, 22:39 UTC

Market Talk

Sales Growth, Flu Season in Focus at F&P Healthcare's 1H Result -- Market Talk

2 sept. 2024, 23:56 UTC

Market Talk

Fisher & Paykel's Growth Outlook Looks Attractive -- Market Talk

30 mai 2024, 00:44 UTC

Market Talk
Câștiguri

Fisher & Paykel FY 2025 Guidance Hinges on Currency -- Market Talk

29 mai 2024, 23:35 UTC

Market Talk

Fisher & Paykel to Benefit From FX Tailwinds -- Market Talk

28 mai 2024, 22:43 UTC

Market Talk

Fisher & Paykel Healthcare Making Progress in Improving Margins -- Market Talk

28 mai 2024, 20:59 UTC

Câștiguri

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Net Profit After Tax NZ$310M to NZ$360M

28 mai 2024, 20:58 UTC

Câștiguri

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Rev NZD1.9B-NZD2B

28 mai 2024, 20:57 UTC

Câștiguri

Fisher & Paykel Healthcare Corp. Ltd. FY24 Net Profit After Tax NZ$132.6M

28 mai 2024, 20:56 UTC

Câștiguri

Fisher & Paykel Healthcare Corp. Ltd. FY24 Rev NZD1.742B

24 apr. 2024, 02:38 UTC

Market Talk

F&P Healthcare's Prospects Brighten on Anaesthesia Opportunity -- Market Talk

Comparație

Modificare preț

Fisher & Paykel Healthcare Corp Ltd Așteptări

Obiectiv de preț

By TipRanks

20.89% sus

Prognoză pe 12 luni

Medie 37.453 AUD  20.89%

Maxim 42.7 AUD

Minim 35 AUD

În baza a 6 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruFisher & Paykel Healthcare Corp Ltd - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

6 ratings

3

Cumpărare

1

Păstrare

2

Vânzare

Sentiment

By Acuity

166 / 192 Clasament în Imobiliare

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.